Public Company

Adicet Bio

Universal off-the-shelf T cell therapy for cancer

About

Adicet is a biotechnology company engaged in the development of first-in-class off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases.

Overview

Founded 2014
Type Public
Longevity related Yes
Location Boston, Massachusetts, USA

Latest News

Stock

ACET

Join the Insiders Club.

Plain English. Every week. Free.